Table 5.
Associations of Oxford-VR side effects checklist factor scores
| Oxford-VR side effects checklist factor scores | ||||
|---|---|---|---|---|
| Difficulties concentrating when wearing a headset | Feelings of panic using VR | Worries following VR | Feeling valued | |
| R p Value (n) | R p Value (n) | r p Value (n) | r p Value (n) | |
| Baseline measures | ||||
| Agoraphobic avoidance (O-AS) | −0.05 | −0.00 | −0.02 | −0.90 |
| 0.572 | 0.981 | 0.819 | 0.323 | |
| (117) | (117) | (117) | (117) | |
| Agoraphobic distress (O-AS) | −0.02 | 0.01 | 0.05 | 0.09 |
| 0.833 | 0.955 | 0.620 | 0.344 | |
| (118) | (118) | (118) | (118) | |
| Agoraphobia (AMI) | −0.02 | 0.03 | 0.07 | −0.02 |
| 0.828 | 0.716 | 0.453 | 0.819 | |
| (114) | (114) | (114) | (114) | |
| Paranoia – reference (R-GPTS) | −0.07 | −0.03 | −0.12 | 0.07 |
| 0.479 | 0.770 | 0.221 | 0.466 | |
| (108) | (108) | (108) | (108) | |
| Paranoia – persecutory (R-GPTS) | −0.10 | −0.11 | −0.16 | 0.11 |
| 0.306 | 0.272 | 0.098 | 0.255 | |
| (108) | (108) | (108) | (108) | |
| Paranoia – total (R-GPTS) | −0.09 | −0.08 | −0.15 | 0.10 |
| 0.345 | 0.421 | 0.118 | 0.305 | |
| (108) | (108) | (108) | (108) | |
| Paranoia worries (PWQ) | −0.04 | −0.08 | −0.07 | 0.15 |
| 0.685 | 0.412 | 0.502 | 0.116 | |
| (107) | (107) | (107) | (107) | |
| Depression (PHQ-9) | −0.06 | −0.08 | −0.01 | −0.10 |
| 0.511 | 0.431 | 0.922 | 0.306 | |
| (112) | (112) | (112) | (112) | |
| Threat cognitions (O-CDQ) | −0.05 | 0.02 | 0.02 | −0.01 |
| 0.579 | 0.855 | 0.862 | 0.881 | |
| (116) | (116) | (116) | (116) | |
| Avoidance (O-CDQ) | −0.08 | −0.00 | 0.12 | 0.03 |
| 0.370 | 0.982 | 0.209 | 0.737 | |
| (116) | (116) | (116) | (116) | |
| Within-situation defences (O-CDQ) | −0.04 | −0.02 | −0.04 | 0.15 |
| 0.701 | 0.802 | 0.659 | 0.119 | |
| (116) | (116) | (116) | (116) | |
| Recovery (QPR) | 0.06 | −0.02 | −0.09 | 0.18 |
| 0.535 | 0.853 | 0.319 | 0.058 | |
| (118) | (118) | (118) | (118) | |
| Voices | 0.01 | −0.01 | 0.02 | −0.01 |
| 0.953 | 0.908 | 0.843 | 0.930 | |
| (107) | (107) | (107) | (107) | |
| Hopelessness (BHS) | −0.14 | −0.21* | −0.13 | −0.09 |
| 0.142 | 0.028 | 0.177 | 0.387 | |
| (107) | (107) | (107) | (107) | |
| Therapy time | ||||
| Total number of sessions | −0.15 | −0.05 | −0.12 | −0.06 |
| 0.103 | 0.596 | 0.185 | 0.520 | |
| (118) | (118) | (118) | (118) | |
| Total time in VR | −0.17 | −0.11 | −0.08 | −0.07 |
| 0.074 | 0.254 | 0.377 | 0.429 | |
| (118) | (118) | (118) | (118) | |
| Primary outcomes | ||||
| Change in avoidance (0–6 weeks) | −0.03 | −0.08 | −0.08 | 0.09 |
| 0.790 | 0.422 | 0.384 | 0.326 | |
| (114) | (114) | (114) | (114) | |
| Change in avoidance (0–26 weeks) | −0.09 | −0.03 | −0.03 | 0.01 |
| 0.337 | 0.785 | 0.726 | 0.906 | |
| (111) | (111) | (111) | (111) | |
| Change in distress (0–6 weeks) | −0.07 | −0.00 | −0.03 | 0.25* |
| 0.490 | 0.991 | 0.721 | 0.008 | |
| (115) | (115) | (115) | (115) | |
| Change in distress (0–26 weeks) | −0.01 | −0.03 | −0.01 | 0.17 |
| 0.882 | 0.733 | 0.934 | 0.074 | |
| (111) | (111) | (111) | (111) | |
*p < 0.05.